Pulmonary volumes and capacities determined by spirometry in ex-smokers
Determinación por espirometría de volúmenes y capacidades pulmonares en sujetos exfumadores
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
INTRODUCTION: respiratory diseases are one of the main public health problems for the global economy. One of the main risk factors is smoking. Pulmonary function tests, such as spirometry, allow us to determine the alterations of the respiratory system and its evolution from quantitative values.
OBJECTIVE: the purpose of this research is to determine lung volumes and capacities in ex-smokers through spirometry.
MATERIALS AND METHODS: Cross-sectional, descriptive and observational study with 848 subjects of both genders, older than 16 years of age, ex-smokers older than one year of abandonment, with an average age of 36.62 ± 10.15 (men: 36.62 ± 10.13 vs. women: 40.36 ± 15.86). The pulmonary function is determined by spirometry with the New Spirobank II® equipment, which allows determining, among others, the forced vital capacity (FVC), vital capacity (VC) and forced expiratory volume in one second (FEV1).
RESULTS: 848 subjects, 3.3 % women and 96.7 % men, with an age of 36.62 ± 10.15 years, height of 169.71 ± 6.77 cm, and a weight of 72.66 ± 12,56. Tobacco abstinence of 4.34 years ± 5.27 in a relative daily consumption of 5.76 ± 7.28 cigarettes per day. FEV1/FVC of 87.28 %, FEV1 of 3.81 L ± 0.02 and FVC of 4.38 L ± 0.02. Of the subjects, 754 (88.92 %) had normal FEV1/FVC values and 54 (6.37 %) had mild pulmonary obstruction after having quit smoking.
CONCLUSIONS: the consumption of tobacco reduces the parameters of lung capacities and volumes in people independent of the anthropometric characteristics. The abandonment of smoking can prevent alterations in lung function indifferent from the moment it is suspended.
Article visits 2465 | PDF visits 1816
Downloads
- Dempsey TM, Scanlon PD. Pulmonary Function Tests for the Generalist: A Brief Review. Mayo Clin Proc. 2018;93(6):763-771. doi:10.1016/j.mayocp.2018.04.009.
- Dancer R, Thickett, D. Assessment of pulmonary function. Medicine, 2016;44(4):226–9. doi:10.1016/j.mpmed.2016.02.007
- World Health Organization [Internet]. Geneva: WHO; 2007.Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Disponible en:http://www.who.int/gard/publications/GARD_Manual/en/
- Burney PG, Patel J, Newson R, Minelli C, Naghavi M. Global and regional trends in COPD mortality, 1990-2010. Eur Respir. 2015;45(5):1239–1247. doi:10.1183/09031936.00142414
- World Health Organization [Internet]. Luxemburgo: World Health Organization; 2015. WHO report on the global tobacco epidemic, 2015: raising taxes on tobacco. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/178574/9789240694606_eng.pdf;jsessionid=1F005E6C35C8001D3B8EE060C75B0545?sequence=1
- Talaminos-Barroso A, Márquez-Martín E, Roa-Romero LM, Ortega-Ruiz F. Factores que afectan a la función pulmonar: una revisión bibliográfica. Arch Bronconeumol. 2018;54(6):327–32. doi:10.1016/j.arbres.2018.01.030
- Scanlon PD. Respiratory function: mechanisms and testing. En: Goldman L, Schafer AI, editores. Goldman-Cecil Medicine. 25.a ed. Philadelphia, PA: Elsevier Saunders. 2016. p. 539-45.
- Álvarez FJ, Barchilón V, Casas F, Compán MV, Entrenas LM, Fernández J, et al. Documento de Consenso sobre la espirometría en Andalucía. SEMERGEN. 2009;35(9):457-68. doi:10.1016/S1138-3593(09)72845-X
- Hwang JW, Sundar IK, Yao H, Sellix MT, Rahman I. Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway. FASEB J. 2014;28(1):176–94.doi:10.1096/fj.13-232629
- Mottram C. Ruppel’s Manual of Pulmonary Function Testing.10.a edición. Mary-land Heights, Missouri: Mosby; 2012. p. 3.
- Farha S, Asosingh K, Laskowski D, Licina L, Sekiguchi H, Sekigushi H, et al. Pulmonary gas transfer related to markers of angiogenesis during the menstrual cycle. J Appl Physiol, 2007;103(5):1789–95. doi:10.1152/japplphysiol.00614.2007
- Löfstedt H, Hagström K, Bryngelsson IL, Holmström M, Rask-Andersen A. Respiratory symptoms and lung function in relation to wood dust and monoterpene exposure in the wood pellet industry. Ups J Med Sci. 2017;122(2):78–84. doi:10.1080/03009734.2017.1285836
- Bowatte G, Lodge CJ, Knibbs LD, Lowe AJ, Erbas B, Dennekamp M, et al. Traffic related air pollution exposure is associated with allergic sensitization, asthma, and poor lung function in middle age. J Allergy Clin Immunol. 2017;139(1):122–9.e1. doi:10.1016/j.jaci.2016.05.008
- Rice MB, Li W, Wilker EH, Gold DR, Schwartz J, Koutrakis P, et al. Extreme temperatures and lung function in the Framingham Heart Study. A59 Epidemiology of Airways and Chronic Lung Disesases. 2017;A2042-A2042.12.
- Kobayashi S, Hanagama M, Yamanda S, Satoh H, Tokuda S, Kobayashi M, et al. Impact of a large-scale natural disasteron patients with chronic obstructive pulmonary disease: The aftermath of the 2011 Great East Japan Earthquake. RespirInvestig. 2013;51(1):17–23. doi:10.1016/j.resinv.2012.10.004
- Donnelly PM, Yang TS, Peat JK, Woolcock AJ. What factors explain racial differences in lung volumes? Eur Respir J.1991;4(7):829–38.
- Barone-Adesi F, Dent JE, Dajnak D, Beevers S, Anderson HR, Kelly FJ, et al. Long-term exposure to primary traffic pollutants and lung function in children: Cross-sectional study and meta-analysis. PLoS One. 2015;10(11):e0142565. doi:10.1371/journal.pone.0142565
- Tabak C, Spijkerman AM, Verschuren WM, Smit HA. Does educational level influence lung function decline (Doe-tinchem Cohort Study)? Eur Respir J. 2009;34(4):940–7.doi:10.1183/09031936.00111608
- Lange P, Marott JL, Vestbo J, Ingebrigtsen TS, Nordestgaard BG. Socioeconomic status and prognosis of COPD in Denmark. COPD. 2014;11(4):431–7. doi:10.3109/15412555.2013.869580
- Dane DM, Lu H, Dolan J, Thaler CD, Ravikumar P, Hammond KA, et al. Lung function and maximal oxygen uptake indeer mice (Peromyscus maniculatus) bred at low altitude and reacclimatized to high altitude. FASEB J. 2016;30,1297.51297. doi: 10.1096/fasebj.30.1_supplement.1297.5
- Mehari A, Afreen S, Ngwa J, Setse R, Thomas AN, PoddarV, et al. Obesity and Pulmonary Function in African Americans. PLoS One. 2015;10:e0140610. doi:10.1371/journal.pone.0140610
- Shan X, Liu J, Luo Y, Xu X, Han Z, Li H. Relationship between nutritional risk and exercise capacity in severe chronicobstructive pulmonary disease in male patients. Int J Chron Obstruct Pulmon Dis. 2015;10:1207–12. doi:10.2147/COPD.S82082
- Lazovic B, Mazic S, Suzic-Lazic J, Djelic M, Djordjevic-Saranovic S, Durmic T, et al. Respiratory adaptations in different types of sport. Eur Rev Med Pharmacol Sci.2015;19(12):2269–74.
- Hoesein FA, Jong PA, Lammers JW, Mali WP, Mets OM,Schmidt M, et al. Contribution of CT quantified emphyse- ma, air trapping and airway wall thick-ness on pulmonary function in male smokers with and without COPD. COPD.2014;11(5):503–9. doi:10.3109/15412555.2014.933952
- Gouna G, Rakza T, Kuissi E, Pennaforte T, Mur S, StormeL. Positioning effects on lung function and breathing pattern in premature newborns. J Pediatr. 2013;162(6):1133-7.doi:10.1016/j.jpeds.2012.11.036
- Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):11071136. doi:10.1164/ajrccm.152.3.7663792
- Clotet J, Gómez X, Ciria C, Albalad JM. La espirometría es un buen método para la detección y el seguimiento de la EPOC en fumadores de alto riesgo en atención primaria. Arch Bronconeumol. 2004;40(4):155-9. doi: 10.1016/S03002896(04)75495-2
- Reyes D, García M, Simón P, Pérez K. Repercusión del hábito de fumar en la función pulmonar de fumadores activos. Rev Cub Med Mil. 2011;40(3-4), 227-33.
- Muñoz-Pérez MJ, Palafox D, Palafox J, Vichido-Luna MA, Espinosa N, Rivas-Chávez A. Determinación de valores espirométricos en jóvenes fumadores y no fumadores. Med Int Mex. 2013;29(6):553-557.
- Martínez-López E, Díaz PA. Tabaquismo y disminución de la función pulmonar en hombres y mujeres adultos. Salud(i) ciencia. 2013;20(3):246-250.
- Puhan MA, García-Aymerich J, Frey M, ter Riet G, Anto JM, Agusti AG, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet.2009;374(9691):704-11. doi:10.1016/S0140-6736(09)61301-5
- Soler-Cataluña JJ, Martínez-García MA, Sánchez LS, Tordera MP, Sánchez PR. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med. 2009;103(5):692-9. doi:10.1016/j.rmed.2008.12.005
- Schembri S, Anderson W, Morant S, Winter J, Thompson P,Pettitt D, et al. A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respir Med. 2009;103(10):1461-7. doi:10.1016/j.rmed.2009.04.021.
Information
Journal history
Keywords
Directories and indexes
